Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 22   

Articles published

ATOS 1.28 +0.07 (5.79%)
price chart
Atossa Genetics loses $10.7M in 2013
Atossa Genetics Inc. reported a fiscal 2013 loss of $10.7 million, or a loss of 70 cents per share, which is greater than the 2012 loss of $5.1 million, or 41 cents per share.
Atossa Genetics to Announce 2013 Financial Results and Provide a Company ...
SEATTLE, WA, Mar 24, 2014 (Marketwired via COMTEX) -- Atossa Genetics, Inc. (NASDAQ:ATOS) today announced that it will issue financial results and corporate developments for the fiscal year ended December 31, 2013, following the close of market on ...
Related articles »  
Atossa Genetics Inc.: Atossa Genetics Announces 2013 Financial Results and ...
SEATTLE, WA -- (Marketwired) -- 03/27/14 -- Atossa Genetics, Inc. (NASDAQ: ATOS) today announced 2013 financial results and provided an update on recent corporate developments.
Related articles »  
Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global ...
SEATTLE, WA, Apr 02, 2014 (Marketwired via COMTEX) -- Atossa Genetics, Inc. (NASDAQ:ATOS) announced today that Ben R. Chen has joined the Company as Senior Vice President of Global Regulatory Affairs and Quality Assurance, a newly created ...
Atossa Genetics Inc.: Ben R. Chen Joins Atossa Genetics as Senior Vice ...  The Wall Street Transcript
Related articles »  
Healthcare New Lows: BioTime (NYSEMKT:BTX), Celsion Corporation ...
Celsion Corporation (NASDAQ:CLSN) yearly performance is -26.85%. Atossa Genetics, Inc. (NASDAQ:ATOS) announced 2013 financial results and provided an update on recent corporate developments.
Related articles »  
US/Canada daily earnings hits & misses March 27 - 1800 ET
... SYSTEMS INC Q4 UNDESIGNATED CONR SVC USD -0.12 -0.17 -0.05 56.3 55.6 -0.8 AFRICA OIL CORP Q4 OIL USD -0.02 -0.05 -0.03 0.0 0.0 0.0 ARGOS THERAPEUTICS INC Q4 DRUGS USD -2.63 -36.19 -33.56 1.9 0.7 -1.2 ATOSSA GENETICS INC ...
Related articles »  
After-Hours Earnings Report for March 27, 2014 : RHT, RH, OXM, PRGS, MBLX ...
Atossa Genetics Inc. ( ATOS ) is reporting for the quarter ending December 31, 2013. The medical instruments company's consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.20.
Atossa Genetics elects Ben R Chen as SVP of its Global Regulatory Affairs and ...
Apr 03, 2014 (Menafn - M2 EQUITYBITES via COMTEX) --Breast health company Atossa Genetics ATOS revealed on Wednesday the appointment of Ben R Chen as senior vice president of its Global Regulatory Affairs and Quality Assurance.